Global Preventive Vaccines Market - Trends and Forecasts (2015-2020) - Expected to Reach USD 55 Billion - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Preventive Vaccines Market- Trends and Forecasts (2015-2020)" report to their offering.

The vaccine market accounts for a relatively small market share (2-3%) of the global pharmaceutical market sales. The global preventive vaccines market accounted for a market share of USD 30 billion in 2015 and is expected to reach USD 55 billion by 2020. Once a commodity market with low margins, the vaccines on the market now include blockbusters and mega blockbusters.

New candidates for vaccination against cancers and HIV which are under development are also projected to hit the magical milestone. Multinational vaccine companies historically have conducted much of the innovation, research, and development in the field of vaccine production.

They have used significant revenues, global size, and deeper expertise to fund these R&D efforts. New technologies are also being introduced to curb the time and expense incurred for new vaccine discovery and production. But despite the success of vaccines, infectious diseases are still a major cause of illnesses worldwide and at least 40 major infectious diseases are still uncontrolled by vaccination.

There are currently close to 120 new vaccines in the pipeline of various companies across the globe set to hit the market in the next 5 years to come. In anticipation of this and with the emergence of new target markets and smaller players into the market, the Global vaccine market is set to grow by a CAGR of close to 12.4% till the year 2020.

Companies Mentioned:

  • Sanofi Avnetis
  • Merck
  • GlaxoSmithKline
  • Novartis
  • Pfizer
  • Serum institute

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview and Industry Trends

6. Drivers, Restraints, Opportunities and Challenges Analysis

7. Market Segmentation

8. Market Segmentation by Geography - Regional Share and forecast

9. Competitive Landscape

10. Key Vendor Analysis

11. Analyst Outlook for Investment Opportunities

12. Future Outlook of the Market

For more information visit http://www.researchandmarkets.com/research/44jf5s/global_preventive.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Vaccines

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Vaccines